286 related articles for article (PubMed ID: 33809032)
1. Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections.
Vinuesa V; McConnell MJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809032
[TBL] [Abstract][Full Text] [Related]
2. Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles' heel of antibiotic-resistant microbes.
Holbein BE; Ang MTC; Allan DS; Chen W; Lehmann C
Environ Chem Lett; 2021; 19(4):2789-2808. PubMed ID: 33907538
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-Resistant
Parquet MDC; Savage KA; Allan DS; Ang MTC; Chen W; Logan SM; Holbein BE
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209004
[No Abstract] [Full Text] [Related]
4. Promises and failures of gallium as an antibacterial agent.
Minandri F; Bonchi C; Frangipani E; Imperi F; Visca P
Future Microbiol; 2014; 9(3):379-97. PubMed ID: 24762310
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii.
de Léséleuc L; Harris G; KuoLee R; Chen W
Antimicrob Agents Chemother; 2012 Oct; 56(10):5397-400. PubMed ID: 22825117
[TBL] [Abstract][Full Text] [Related]
6. Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.
Goss CH; Kaneko Y; Khuu L; Anderson GD; Ravishankar S; Aitken ML; Lechtzin N; Zhou G; Czyz DM; McLean K; Olakanmi O; Shuman HA; Teresi M; Wilhelm E; Caldwell E; Salipante SJ; Hornick DB; Siehnel RJ; Becker L; Britigan BE; Singh PK
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257953
[TBL] [Abstract][Full Text] [Related]
7. Iron should be restricted in acute infection.
Scott CR; Holbein BE; Lehmann CD
Front Biosci (Landmark Ed); 2020 Jan; 25(4):673-682. PubMed ID: 31585910
[TBL] [Abstract][Full Text] [Related]
8. Design of iron chelators with therapeutic application.
Zhou T; Ma Y; Kong X; Hider RC
Dalton Trans; 2012 Jun; 41(21):6371-89. PubMed ID: 22391807
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity
Choi SR; Talmon GA; Hearne K; Woo J; Truong VL; Britigan BE; Narayanasamy P
Mol Pharm; 2023 Aug; 20(8):4058-4070. PubMed ID: 37471668
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
Islam S; Jarosch S; Zhou J; Parquet Mdel C; Toguri JT; Colp P; Holbein BE; Lehmann C
J Surg Res; 2016 Jan; 200(1):266-73. PubMed ID: 26235905
[TBL] [Abstract][Full Text] [Related]
11. Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.
Chitambar CR; Antholine WE
Antioxid Redox Signal; 2013 Mar; 18(8):956-72. PubMed ID: 22900955
[TBL] [Abstract][Full Text] [Related]
12. Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections.
Bruhn KW; Spellberg B
Curr Opin Microbiol; 2015 Oct; 27():57-61. PubMed ID: 26261881
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of gallium-based drugs for antibacterial therapy.
Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
[TBL] [Abstract][Full Text] [Related]
14. Design of clinically useful iron(III)-selective chelators.
Liu ZD; Hider RC
Med Res Rev; 2002 Jan; 22(1):26-64. PubMed ID: 11746175
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
Harrington JM; Mysore MM; Crumbliss AL
Dalton Trans; 2018 May; 47(20):6954-6964. PubMed ID: 29721567
[TBL] [Abstract][Full Text] [Related]
16. Metallotherapeutics development in the age of iron-clad bacteria.
Centola G; Xue F; Wilks A
Metallomics; 2020 Dec; 12(12):1863-1877. PubMed ID: 33242314
[TBL] [Abstract][Full Text] [Related]
17. The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies.
Kontoghiorghes GJ; Kolnagou A; Skiada A; Petrikkos G
Hemoglobin; 2010 Jun; 34(3):227-39. PubMed ID: 20524813
[TBL] [Abstract][Full Text] [Related]
18. Exploiting bacterial iron acquisition: siderophore conjugates.
Ji C; Juárez-Hernández RE; Miller MJ
Future Med Chem; 2012 Mar; 4(3):297-313. PubMed ID: 22393938
[TBL] [Abstract][Full Text] [Related]
19. Harnessing microbial iron chelators to develop innovative therapeutic agents.
Ribeiro M; Sousa CA; Simões M
J Adv Res; 2022 Jul; 39():89-101. PubMed ID: 35777919
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant
Vinuesa V; Cruces R; Nonnoi F; McConnell MJ
Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34065605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
